AGARVEY LLC — Department of Defense SBIR Phase I: X224-OCSO1
AGARVEY LLC — SBIR Phase I award from Department of Defense.
- Amount
- $75,000
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- X224-OCSO1
- Solicitation
- X22.4
- NAICS
- —
- Place of performance
- OH
- Period
- 2022-11-04 → 2023-02-04
Description
Pathogens such as MRSA, SARs, Monkey Pox are only a sample of diseases effecting the general population. Frontline emergency personnel and especially the military are exposed to additional diseases and often treat individuals with unknown diseases. Tools and PPE used to military personnel are susceptible to contamination especially shared items and this can result in the transmission of surface and inner layer pathogens causing illness and mission downtime or replacement of isolated personnel. Decontamination of surfaces is vital to prevent contraction of bacterial and viral infections. AGarvey uses a patented process for decontamination surfaces and inner layers of fabrics: Blue Light and or UVC irradiation, air movement decontamination and electric fields. This trifecta of non solvent decontamination is unique in the industry.